drugset / Trial / NCT01383486
Self Selection Trial of Naproxen Sodium
Non-randomizedParallel-groupOpen-label
Summary
A pilot trial to demonstrate that consumers can appropriately select Aleve 24 Hour for their own use based on expected duration of pain greater than 12 hours.
Timeline
- Start
- 2011-07
- Primary completion
- 2011-08
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibuprofen | Small molecule | 200 mg | Oral |
| Subject | Naproxen | Small molecule | 660 mg | Oral |
Indications
No indication recorded.